Veröffentlichungen 2002
Publikationen
1. Brix G, Bellemann ME, Ziegler SI, Haberkorn U. Quantification of F-18-FDG up-take in the liver using dynamic PET-Reply. J Nucl Med 2002;43:439-441.
2. Clorius JH, Haufe S, Schlotmann A, Haberkorn U. Exercise renography in essential hypertension. Q J Nucl Med 2002; 46(4):311-318.
3. Dimitrakopoulou-Strauss A. The role of Positron Emission Tomography (PET) for diagnosis and therapy monitoring in oncology. Contemporary Medicine 2002;2:16-24.
4. Dimitrakopoulou-Strauss A, Strauss LG, Heichel T, Wu H, Burger C, Bernd L, Ewerbeck V. The role of quantitative (18)F-FDG PET studies for the differentiation of malignant and benign bone lesions. J Nucl Med 2002;43:510-518.
5. Efferth T, Koomägi R, Mattern J, Volm M. Expression profile of proteins involved in the xenotransplantability of non-small cell lung cancers into athymic nude mice. Int J Oncol 2002;20:391-395.
6. Eisenhut M, Mohammed A, Mier W, Schönsiegel F, Friebe M, Mahmood A, Jones AG, Haberkorn U. Melanoma uptake of Tc-99m complexes containing the N-(2-Diethylaminoethyl)benzamide structural element. J Med Chem 2002; 45:5802-5805.
7. Graham KAN, Wang Q, Eisenhut M, Haberkorn U, Mier W. A general method for functionalising both the C- and N-terminals of Tyr(3)-octreotate. Tetrahedron Letters 2002;43(29):5021-5024.
8. Gutschalk A, Kollmar R, Mohr A, Henze M, Ille N, Schwaninger M, Hartmann M, Hähnel S, Haberkorn U, Rupp A, Meyding-Lamade U. Multimodal functional imaging of prolonged neurological deficits in familial hemiplegic migraine. Neurosci Lett 2002;332:115-118.
9. Haberkorn U, Altmann A. Radionuclide imaging in the postgenomic era. J Cell Biochem 2002;39:1-10.
10. Haberkorn U, Altmann A, Eisenhut M. Functional genomics and proteomics - the role of nuclear medicine. Eur J Nuc Med 2002;29:115-132.
11. Henze M, Mohammed A, Mier W, Rudat V, Dietz A, Nollert J, Eisenhut M, Haberkorn U. Pretreatment evaluation of carcinomas of the hypopharynx and larynx with F-18-fluorodeoxyglucose, I-123-alpha-methyl-L-tyrosine and Tc-99m-hexakis-2-methoxyisobutylisonitrile. Eur J Nucl Med 2002;29:324-330.
12. Henze M, Mohammed A, Schlemmer H, Herfarth KK, Mier W, Eisenhut M, Debus J, Haberkorn U. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[(123)I]iodo-alpha-methyl-L-tyrosine and (99m)Tc-MIBI SPET. Eur J Nucl Med 2002;29:1455-1461.
13. Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Frölich L, Schönknecht P, Ito K, Mielke R, Kalbe E, Zündorf G, Delbuecke X, Pelati O, Anchisi D, Fazio F, Kerrouche N, Desgranges B, Eustache F, Beuthien-Baumann B, Menzel C, Schröder J, Kato T, Arahata Y, Henze M, Heiss WD. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET. Neuroimage 2002;17:302-316.
14. Kontaxakis G, Strauss LG, Thireou T, Ledesma-Carbayo MJ, Santos A, Pavlopoulos S, Dimitrakopoulou-Strauss A. Iterative image reconstruction for clinical PET using ordered subsets, median root prior, and a web-based interface. Mol Imag Biol 2002;4:219-231.
15. Lichy MP, Henze M, Sammet S, Maudsley AA, Bachert P, Debus J, Schlemmer HP. Clinical decision making in irradiated gliomas: Value of Proton MR Spectroscopy compared to FDG-PET and IMT-SPECT. J Magn Reson Imaging 2002;4:575-576.
16. Martin SJ, Eisenbarth JA, Wagner-Utermann U, Mier W, Henze M, Pritzkow H, Haberkorn U, Eisenhut M. A New Precursor for the Radiosynthesis of [18F]FLT. Nucl Med Biol 2002;29:263-273.
17. Mattern J, Koomägi R, Volm M. Expression of drug resistance gene products during progression of lung carcinomas. Oncol Rep 2002;9:1181-1184.
18. Mattern J, Koomägi R, Volm M. Characteristics of long-term survivors of untreated lung cancer. Lung Cancer 2002;36:277-282.
19. Mier W, Haberkorn U, Eisenhut M. [18F]FLT; Portrait of a Proliferation Marker. Eur J Nucl Med 2002;29:165-169.
20. Rohrschneider WK, Haufe S, Wiesel M, Tönshoff B, Wunsch R, Darge K, Clorius JH, Tröger J. Functional and morphologic evaluation of congenital urinary tract dilatation by using combined static-dynamic MR urography: Findings in kidneys with a single collecting system. Radiology 2002;224:683-694.
21. Rohrschneider WK, Haufe S, Möhring K, Wiesel M, Tönshoff B, Clorius JH, Tröger J. Kombinierte statisch-dynamische MR-Urographie zur morphologisch funktionellen Diagnostik angeborener Harntransportstörungen (Combined static-dynamic MR urography for simultaneous morphological and functional diagnosis of congenital urinary tract obstruction). Aktuelle Urologie 2002;33:341-350.
22. Schlemmer HP, Lichy MP, Henze M, Sammet S, Maudsley AA, Debus J, Bachert P. Proton MR spectroscopy in irradiated brain tumors. J Magn Reson Imaging 2002;4:2040-2041.
23. Schlemmer HP, Bachert P, Henze M, Buslei R, Herfarth KK, Debus J, van Kaick G. Differentiation of radiation necrosis from tumor progression using proton magnetic resonance spectroscopy. Neuroradiology 2002;44:216-222.
24. Volm M, Koomägi R, Mattern J, Efferth T. Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients. Clin Cancer Res 2002;8:1843-1848.
25. Volm M, Koomägi R, Mattern J, Efferth T. Protein expression profile of primary human squamous cell lung carcinomas indicative of the incidence of metastases. Clin Exp Metast 2002;19:385-390.
26. Volm M, Koomägi R, Efferth T, Mattern J. Protein expression profiles of non-small cell lung carcinomas: correlation with histological subtype. Anticancer Res 2002;22:2321-2324.
27. Volm M, Koomägi R, Mattern J, Efferth T. Protein expression profiles indicative for drug resistance of non-small cell lung cancer. Br J Cancer 2002;87:251-257.
28. Weigand M, Hartung G, Roboz J, Sieger S, Wolf M, Sinn H, Schrenk HH, Wiessler M, Frei E. Mode of action of methotrexate-albumin in a human T-cell leukemia line and activity against an MTX-resistant clone. Anti-Cancer Drug Design 2002;16:227-237.
29. Wu H, Dimitrakopoulou-Strauss A, Heichel TO, Lehner B, Bernd L, Ewerbeck V, Burger C, Strauss LG. Quantitative evaluation of skeletal tumors with dynamic Fluorine-18-Fluordeoxyglucose (FDG) PET. Chin J Nucl Med 2002;22:77-80.
30. Zitzmann S, Askoxylakis V, Mier W. Phagen-Display Bibliotheken: mit Viren auf der Suche nach neuen Targets. Bioforum 2002;25:490-491.
Buchbeiträge
1. Haberkorn U. Imaging Gene Expression. In: Wahl R (ed.) Clinical Positron Emission Tomography: Principles and Practice. Lippincott Williams and Wilkins Philadelphia: 2002; pp 420-430.
2. Haberkorn U. Positronenemissionstomographie. In: Drings P, Dienemann H, Wannenmacher M (ed.). Management des Lungenkarzinoms. Springer Verlag, Heidelberg; 2002; pp 125-133.
3. Henze M. Chapter 1: Craniocerebral Diseases – Nuclear Medicine Imaging. In: Diagnostic and Interventional Neuroradiology – A Multimodality Approach (ed.) Sartor K, Georg Thieme Verlag Stuttgart, New York 2002; pp 35-40.
4. Henze M. Chapter 2: Spinal Diseases – Nuclear Medicine Imaging. In: Diagnostic and Interventional Neuroradiology – A Multimodality Approach (ed.) Sartor K, Georg Thieme Verlag Stuttgart, New York 2002; pp 277-280.